Holen Sie sich die Stockscreener-App
85.08
0.40%
0.325
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$84.76
Offen:
$85.69
24-Stunden-Volumen:
414.38K
Relative Volume:
0.31
Marktkapitalisierung:
$9.51B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
36.21
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
-6.84%
1M Leistung:
-11.39%
6M Leistung:
+2.68%
1J Leistung:
-22.87%
1-Tages-Spanne:
$83.48
$86.40
1-Wochen-Bereich:
$83.48
$92.84
52-Wochen-Spanne:
$81.36
$118.30
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
85.08 | 9.48B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
469.73 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.60 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
572.36 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.63 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.72 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Goldman | Neutral |
| 2025-10-16 | Eingeleitet | Guggenheim | Neutral |
| 2025-05-01 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
Stifel reiterates Hold on Revvity stock, keeps $110 price target - Investing.com
Barclays PLC Sells 37,149 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity at Conference Barclays: Strategic Insights for Growth - Investing.com
Understanding Momentum Shifts in (RVTY) - Stock Traders Daily
How The Revvity (RVTY) Narrative Is Shifting With Higher Targets And Tempered Growth Assumptions - Yahoo Finance
Revvity, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Trend Report: Whats the MACD signal for Revvity Inc2025 Market Overview & Comprehensive Market Scan Reports - baoquankhu1.vn
Trading Recap: Is Revvity Inc a play on infrastructure spending2025 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
Tenet Healthcare, Revvity, Avantor, Azenta, and Elanco Shares Plummet, What You Need To Know - Yahoo Finance
Revvity (NYSE: RVTY) virtual annual meeting Apr 28 — key governance votes - Stock Titan
Revvity Inc (RVTY) Stock Price Down 4.85% on Mar 6 - GuruFocus
Bretton Fund Exited Revvity (RVTY) in 2025 - Insider Monkey
Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report? - Yahoo Finance
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - Finviz
RVTY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revvity at TD Cowen: Strategic Growth and Margin Expansion - Investing.com
Revvity at TD Cowen: Strategic Growth and Margin Expansion By Investing.com - Investing.com South Africa
Here's Why Keeping Revvity Stock in Your Portfolio Makes Sense at This Time - Bitget
Citigroup Inc. Has $6.58 Million Stock Position in Revvity Inc. $RVTY - MarketBeat
Reassessing Revvity (RVTY) Valuation After Prolonged Share Price Weakness - simplywall.st
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity Inc (RVTY) Stock Price Down 3.22% on Mar 2 - GuruFocus
Revvity at Raymond James Conference: Strategic Growth and AI Opportunities - Investing.com Nigeria
Transcript : Revvity, Inc. Presents at 47th Annual Raymond James Institutional Investor Conference, Mar-02-2026 07 - marketscreener.com
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
Mitsubishi UFJ Asset Management Co. Ltd. Acquires 16,632 Shares of Revvity Inc. $RVTY - MarketBeat
RVTYRevvity Inc Latest Stock News & Market Updates - Stock Titan
RVTY SEC FilingsRevvity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Revvity Inc Stock Price ($RVTY.RTH), Quote & News - eToro
Revvity (RVTY) Valuation Check After Recent Share Price Weakness - simplywall.st
Revvity (NYSE:RVTY) Rating Increased to Buy at Wall Street Zen - MarketBeat
Cord Blood Banking Services Market: USD 49.85 Bn Opportunity to 2031 Led by Stem Cell Advancements, Says Mordor Intelligence - GlobeNewswire Inc.
Primecap Management Co. CA Reduces Stake in Revvity Inc. $RVTY - MarketBeat
JPMorgan Chase & Co. Has $44.82 Million Position in Revvity Inc. $RVTY - MarketBeat
Avoiding Lag: Real-Time Signals in (RVTY) Movement - Stock Traders Daily
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity (RVTY) insider exercises options then sells 1,862 common shares - Stock Titan
Zacks Research Brokers Lift Earnings Estimates for Revvity - MarketBeat
Revvity’s AI Push Brings Innovation Potential but Heightened Operational, Legal, and Reputational Risks - TipRanks
Insider Sell: Michelle Mcmurry-heath Sells Shares of Revvity Inc (RVTY) - GuruFocus
Revvity (RVTY) director sells 600 shares in open-market trade - Stock Titan
Zacks Research Estimates Revvity's Q1 Earnings (NYSE:RVTY) - MarketBeat
Decoding Revvity Inc (RVTY): A Strategic SWOT Insight - GuruFocus
How Investors May Respond To Revvity (RVTY) Strong Q4 Beat And Upbeat 2026 Outlook - Yahoo Finance
Revvity : Annual Report for Fiscal Year Ending 12/28, 2025 (Form 10-K) - marketscreener.com
[144] REVVITY, INC. SEC Filing - Stock Titan
Revvity Inc. $RVTY Shares Purchased by Envestnet Asset Management Inc. - MarketBeat
Bond Watch: Is Revvity Inc showing insider buyingJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - baoquankhu1.vn
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - The Globe and Mail
Do Wall Street Analysts Like Revvity Stock? - Barchart.com
Vanguard Group Inc. Lowers Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):